ALVAIZ - Trademark Details
Status: 734 - Fifth Extension - Granted
Serial Number
88223031
Word Mark
ALVAIZ
Status
734 - Fifth Extension - Granted
Status Date
2021-11-10
Filing Date
2018-12-10
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-03-12
Law Office Assigned Location Code
N10
Employee Name
BULLOFF, TOBY ELLEN
Statements
Goods and Services
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-01-02
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Teva Pharmaceuticals USA, Inc.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-12-13 | NEW APPLICATION ENTERED IN TRAM |
2019-01-02 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-01-29 | ASSIGNED TO EXAMINER |
2019-01-30 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-02-20 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-03-12 | PUBLISHED FOR OPPOSITION |
2019-03-12 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-05-07 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-11-05 | TEAS EXTENSION RECEIVED |
2019-11-05 | EXTENSION 1 FILED |
2019-11-05 | EXTENSION 1 GRANTED |
2019-11-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-11-05 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-05-04 | TEAS EXTENSION RECEIVED |
2020-05-04 | EXTENSION 2 FILED |
2020-05-04 | EXTENSION 2 GRANTED |
2020-05-06 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-11-02 | TEAS EXTENSION RECEIVED |
2020-11-02 | EXTENSION 3 FILED |
2020-11-02 | EXTENSION 3 GRANTED |
2020-11-04 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-05-07 | TEAS EXTENSION RECEIVED |
2021-05-07 | EXTENSION 4 FILED |
2021-05-07 | EXTENSION 4 GRANTED |
2021-05-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-11-02 | TEAS EXTENSION RECEIVED |
2021-11-04 | TEAS EXTENSION RECEIVED |
2021-11-10 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-11-02 | EXTENSION 5 FILED |
2021-11-10 | EXTENSION 5 GRANTED |
2021-11-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |